HOME > Investors > Press Releases
2017-05-25
2017.05(IR letter) Business Updates
2017-04-04
2016 Annual Report
2017-03-06
2016.06 (IR letter) Business Updates
2017-02-10
VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)
2016-08-02
VM BioPharma Announces Korea Food and Drug Administration Approval of Phase 2 Clinical Trial for Investigational Gene Therapy VM202 in Ischemic Heart Disease
1 2 3 4 5 6 7 8 9 10